I
n March 2013, a novel avian influenza A virus (AIV) strain of subtype H7N9 was found to infect humans in an outbreak in the People's Republic of China (1) . The transmission of the China/ 2013 virus to humans probably occurred at live-bird markets and resulted in a high case fatality rate (2) (3) (4) . Genetic analysis indicates that the virus represents a multiple reassortant with all of the gene segments being of complex avian ancestry. The hemagglutinin (HA) and neuraminidase (NA) genome segments probably descended from viruses of ducks and migratory birds, respectively, whereas the six "internal genes" might have originated from H9N2 viruses circulating in chickens in eastern China (1, 5, 6) . The HA cleavage site of China/2013 contains a monobasic motif, indicating a low-pathogenicity phenotype in gallinaceous poultry (1, 2, (4) (5) (6) . Moreover, sequence analysis revealed several genetic features probably associated with its ability to replicate in mammals, like alterations in the receptor binding site (H5 numbering: G195V, Q235L/I) and loss of a glycosylation site (T169A) within the HA protein, as well as either the E627K or the D701N substitution in PB2 of H7N9 China/2013 viruses isolated from humans (1, (5) (6) (7) (8) (9) . It was shown that the novel avian H7N9 virus can bind to both avian-type (␣2,3-linked sialic acid) and human-type (␣2,6-linked sialic acid) receptors, that it can invade epithelial cells in the human lower respiratory tract and type II pneumocytes in alveoli, and that it replicates efficiently in human ex vivo lung and trachea explant cultures, as well as in several mammalian cell lines (9) . Furthermore, the novel H7N9 virus exhibits a deletion of five amino acids at positions 69 to 73 within the NA stalk domain, which is supposed to be associated with the adaptation of AIVs to domestic, in particular gallinaceous, poultry (7, 10, 11) and increased virulence in mammals (12) .
Outbreaks in poultry caused by low-pathogenicity AIVs (LPAIVs) or highly pathogenic AIVs (HPAIVs) of subtype H7 have occurred repeatedly during the last few years in Europe and North America (reviewed in reference 13). In addition, historic reports have described natural transmission of H7 viruses of avian origin to horses and seals (14, 15) . Before 2013, human infections with LPAIV H7 strains (H7N7, H7N2, H7N3) were reported as well (16) . Studies with mammalian models of influenza A virus infec-tion such as mice and ferrets indicated that H7 viruses, especially those of the Eurasian lineage, replicated efficiently in the respiratory tract without prior adaptation and spread systemically, including to the central nervous system (18, 19) . In another study with selected H7 strains associated with human infections, it was demonstrated that although they display a low-pathogenicity phenotype, these viruses had a propensity to be transmitted between ferrets by direct contact but not by respiratory droplets (20) . Recently, Lam and colleagues identified an H7N7 virus in chickens at live-poultry markets in eastern China that had the same genetic backbone as the avian H7N9 virus and that was able to infect mammals experimentally (21) . Although no human infections with this virus have been reported yet, the authors concluded that H7 viruses in general may pose threats beyond the current outbreak of H7N9 in Southeast Asia.
In the present study, we characterized the infectivity and pathogenicity of a human isolate of the novel avian H7N9 virus, A/Anhui/1/13, in comparison with those of a recent LPAIV H7N7 strain from Germany, A/turkey/Germany/AR534/13. To this end, we infected chickens and pigeons; both species are involved as avian hosts in the current circulation of the H7N9 virus in China (4, 8) . The ferret is considered a suitable mammalian model in which to study the pathogenicity (and transmissibility) of influenza viruses of various origins (22, 23) and was included here to comparatively investigate the pathogenicity to mammals of the novel avian H7N9 virus and a "standard" LP H7N7 virus. Neither the avian H7N9 virus nor the recent H7N7 strain from Germany induced influenza-like symptoms in either avian host species or the ferret model, even at the large infective dose of 10 6 50% tissue culture infective doses (TCID 50 ) used in this study. Nevertheless, we observed greater replication of the novel avian H7N9 virus than of the H7N7 virus in the ferret model, in contrast to the low pathogenicity of both the H7N9 and H7N7 viruses in the avian host species.
MATERIALS AND METHODS
Ethics statement. The animal experiments described here were evaluated by the responsible ethics committee of the State Office of Agriculture, Food Safety, and Fishery in Mecklenburg-Western Pomerania (LALLF M-V) and gained governmental approval under registration numbers LVL MV/TSD/7221.3-2.5-010/10, MV/TSD/7221.3-2.5-010/13, and MV/ TSD/7221.3-2.1-052/09.
Viruses. The novel avian H7N9 virus A/Anhui/1/13 was isolated from a 35-year-old woman from Anhui Province, China, who had visited a chicken market 1 week before the onset of symptoms and died of acute respiratory distress syndrome (1). The virus was kindly provided by the WHO Collaborating Centre, London, United Kingdom, under the auspices of the Pandemic Influenza Preparedness program. The low-pathogenicity H7N7 virus A/turkey/Germany/AR534/2013 represents an H7N7 virus recently detected in outbreaks among gallinaceous poultry in Germany. Both viruses were propagated in the allantoic cavities of 11-day-old embryonated chicken eggs and, after clarification of the harvested allantoic fluids by centrifugation, stored at Ϫ70°C until further use. The genome sequences of A/Anhui/1/13 (H7N9) and A/turkey/Germany/ AR534/2013 (H7N7) [identical to A/turkey/Germany-NI/R534/2013 (H7N7), following the database nomenclature] are available at GISAID's EpiFlu database (www.gisaid.org) (accession numbers EPI439503 to EPI439510, EPI470366, EPI470367, and EPI490869 to EPI490874, respectively). All procedures involving H7N9 and H7N7 viruses were carried out in an approved, enhanced-biosafety level 3ϩ facility.
Experimental infection and sampling of chickens, pigeons, and ferrets. Adult white Leghorn chickens (Gallus gallus domesticus) were purchased from Lohmann Animal Health, Cuxhaven, Germany, while adult racing pigeons (Columba species) were obtained from an AI-free racing pigeon loft. Four chickens and four pigeons per virus group were infected oculonasally (o.n.) with 10 6 TCID 50 of A/Anhui/1/13 (H7N9) or A/turkey/Germany/AR534/13 (H7N7), respectively, and monitored daily for clinical signs for 14 days. They were classified as clinically healthy (score of 0), ill (exhibiting one or more of the following signs of disease: labored breathing, diarrhea, cyanosis, edema, and neurological symptoms) (score of 1), or dead (score of 2) as described previously (24) . Oropharyngeal and cloacal swabs were taken at 2, 4, 7, 10, and 14 days postinfection (dpi) or as combined oropharyngeal-cloacal swabs prior to infection and stored in 1 ml medium. At 2 dpi, two further chickens were placed into direct contact with the H7N9-or H7N7-infected birds, serving as transmission controls. Blood sampling and a postmortem examination of one chicken and one pigeon per virus group were performed at 2 and 4 dpi, respectively, or at the end of the experiment for the remaining birds (two inoculated chickens, two contact chickens, two inoculated pigeons). Euthanized birds were dissected, and the lungs and intestines were removed and stored at Ϫ70°C until further use.
Outbred ferrets (Mustela putorius furo) were reared at the FriedrichLoeffler-Institut and housed in cages in groups of one or three animals per control group or virus group, respectively, during the experiment. The cages were separated by stainless steel grids to prevent direct contact. Six 8-week-old healthy and influenza-negative ferrets in each virus group were infected intranasally (i.n.) under anesthesia by inhalation of 5% isoflurane in O 2 with 10 6 TCID 50 of A/Anhui/1/13 (H7N9) or A/turkey/ Germany/AR534/2013 (H7N7), respectively, and monitored daily for clinical signs (nasal discharge, labored breathing, reduced activity, fever, body weight loss, or neurological symptoms). Two additional ferrets, which were kept in the same room but remained uninfected, served as control animals. Animals were weighed every second day, and body temperatures were recorded with a temperature-logging device (Plexx, Elst, The Netherlands) implanted subcutaneously. Blood samples were drawn from the vena saphena under anesthesia with isoflurane prior to infection or on the day of euthanasia, respectively. Nasal wash samples were collected from all of the ferrets under anesthesia by applying 0.7 ml phosphate-buffered saline (PBS) to each nostril prior to infection and at 2, 4, 6, 8, 10, 12, and 17 dpi. Euthanasia of four animals per virus group and one control ferret at 4 dpi and of the remaining animals at 17 dpi was performed under general anesthesia with isoflurane by means of exsanguination. Euthanized ferrets were dissected, and their spleens, tracheas, lungs (divided into left and right parts), conchae, cerebella, and cerebra were removed and stored at Ϫ70°C until further use.
Organ homogenization. Tissue samples of individual animals were suspended in 1 ml of medium supplemented with 5% fetal bovine serum plus antibiotics. A single stainless steel bead (diameter, 5 mm) per organ sample was added, and samples were homogenized in 2-ml collection tubes for 2 min in a TissueLyser (Qiagen, Hilden, Germany). After subsequent centrifugation at 13,000 rpm for 2 min to remove cellular debris, the supernatant was used to extract viral RNA.
RNA isolation. Viral RNA was extracted from 200 l of the supernatant of organ homogenates or swab samples or nasal wash samples with the MagAttract Virus Mini M48 kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions on a Biosprint 96 platform (Qiagen).
Real-time RT-qPCR. The primer and probe set of the recently described FLI-H7generic-2 assay (25) was used to determine the quantification cycle (C q ) in swabs, nasal wash samples, and organs with the AgPath-ID One-Step RT-PCR kit (Applied Biosystems, Foster City, CA). The quantitative reverse transcription-PCR (RT-qPCR) assay was optimized by using a total volume of 12.5 l. Briefly, for a single well, 2.25 l RNase-free water, 6.25 l 2ϫ RT-PCR buffer, 0.5 l 25ϫ RT-PCR Enzyme Mix, and 1.0 l primer-probe mixture were pooled as a master mixture. Finally, 2.5 l RNA template was added and the reaction was run on an ABI cycler 7500 machine.
Internal extraction control. For IAV screening investigation, the FLIH7generic-2 assay was combined with an internal control system in a duplex assay as described earlier (26) .
Correlation of TCID 50 and viral genome load. For both viruses (H7N9, H7N7), a log 10 dilution series of infectious virus was analyzed by RT-qPCR and by virus titration with Madin-Darby canine kidney (MDCK) cells. Both experiments were performed in triplicate. Regression curves for the H7N9 virus (y ϭ Ϫ3.5289x ϩ 39.719; R 2 ϭ 0.9997) and for the H7N7 virus (y ϭ Ϫ3.7378x ϩ 38.194; R 2 ϭ 0.9996) were established and used to calculate TCID 50 ml Ϫ1 equivalents (TCID 50 -eq) from C q values measured by RT-qPCR in swab and organ samples.
Histopathological and immunohistochemical analyses. Tissues from infected and control animals were placed into 4% phosphate-buffered neutral formaldehyde and processed for paraffin embedding. Paraffin wax sections (2 m) were dewaxed and stained with hematoxylin and eosin. To investigate the presence of influenza A antigen, and sections were stained as described previously (27) .
Serology. Serum samples from all animals were heat inactivated at 56°C for 30 min and analyzed by means of a commercial enzyme-linked immunosorbent assay (ELISA) for the presence or absence of antibodies against IAV nucleoprotein (NP) (ID Screen Influenza A Antibody Competition ELISA kit; ID-vet, Montpellier, France) and H7 (ID Screen Influenza H7 Antibody Competition ELISA kit; ID-vet, Montpellier, France) according to the manufacturer's instructions. HI assays against A/Anhui/ 1/13 (H7N9) and A/turkey/Germany/AR534/13 (H7N7) were performed according to standard protocols (2006/437/EC). A virus neutralization assay was performed as described previously (28) but with a few modifications. Threefold serial dilutions were prepared in 50-l volumes of medium in 96-well plates. Diluted serum samples were mixed with an equal volume of medium containing either the H7N9 or the H7N7 virus at a concentration of 10 2 TCID 50 /well. After incubation (1 h, 37°C, 5% CO 2 ), 100 l of MDCK cells at 1 ϫ 10 5 cells/liter was added to each well. The plates were incubated for 3 days (37°C, 5% CO 2 ), and viral replication was assessed by visual scoring of the cytopathic effect without staining. Each assay was validated by comparison with positive-and negative-control sera and by titration of the virus dilutions used.
Statistics. We used the Wilcoxon rank sum test to evaluate the statistical significance of data measured by qRT-PCR. Because of the small group sizes, only ferret nasal wash samples were suitable for analysis. A P value of Ͻ0.05 was considered significant.
RESULTS
To compare the infectivity, virulence, and organ distribution of the novel H7N9 virus from China with those of an LPAIV H7N7 virus recently circulating in Europe in avian host species, four chickens and four pigeons per virus were inoculated o.n. with 10 6 TCID 50 of A/Anhui/1/13 (H7N9) or A/turkey/Germany/ AR534/13 (H7N7); two chickens and two pigeons, respectively, were sampled and monitored for clinical signs for 14 days, and one bird per virus and species group was euthanized at 2 and 4 dpi for assessment of the viral RNA loads in different organs. To evaluate the transmission of the H7N9 and H7N7 viruses by infected birds, two additional chickens per virus were placed into direct contact at 2 dpi. For experiments with a mammalian model, six ferrets per virus were inoculated i.n. with 10 6 TCID 50 ; two animals were sampled and monitored for symptoms for 14 days, and four ferrets were euthanized at 4 dpi to investigate viral dissemination.
Virulence of H7N9 and H7N7 viruses. After o.n. infection with A/Anhui/1/13 (H7N9) or A/turkey/Germany/AR534/13 (H7N7), none of the chickens showed any signs of disease or died during the 14-day observation period. The contact chickens remained healthy, too. Therefore, the clinical score for both viruses was 0.0, confirming that the novel avian H7N9 virus and the recent H7N7 virus are apathogenic in chickens.
For comparison of the pathogenicity of avian H7N9 virus and the H7N7 virus in the other avian host species, four pigeons per virus group were infected o.n. and observed daily for symptoms. However, infection with A/Anhui/1/13 (H7N9) or A/turkey/Germany/AR534/13 (H7N7) did not result in any clinical signs, proving that both viruses are apathogenic in pigeons as well.
To examine the pathogenicity and zoonotic potential of the novel avian H7N9 virus in comparison with those of a recent H7N7 virus, we infected two ferrets per virus group i.n. and included two uninfected control ferrets. Infection of ferrets with the H7N7 virus caused fever from 2 to 6 dpi, whereas the H7N9 virus caused slightly elevated body temperatures from 2 to 4 dpi, followed by higher temperatures from 6 to 8 dpi (Fig. 1A) . Of note, a minor body temperature elevation was also seen in the control animal, indicating that the infection procedure itself contributed partially to these observations. The ferrets inoculated with A/Anhui/1/13 (H7N9) or A/turkey/Germany/AR534/13 (H7N7) showed a slight delay in body weight gain from 2 to 4 dpi but developed well after that time point (Fig. 1B) . The control ferret was much heavier at the beginning of the experiment and therefore had a more constant body weight throughout the study. Neither the H7N9-or H7N7-infected ferrets nor the mock-in- Measurements were made at the time points indicated while the ferrets were under anesthesia. Body temperature is given as the mean value and standard deviation of the difference from the temperature prior to infection. Body weight is given as the mean value and standard deviation compared to the weight prior to infection. fected animals developed clinical signs like sneezing, nasal discharge, coughing, diarrhea, or lethargy as described previously for ferrets infected with an HPAIV of subtype H7N7 (18) .
Taken together, exposure to H7N9 and H7N7 showed comparable clinically inconspicuous profiles in chickens, pigeons, and ferrets.
Viral replication and shedding of H7N9 and H7N7 viruses. In order to compare the replication of the avian H7N9 and H7N7 viruses in chickens and pigeons and shedding via the respiratory or digestive tract, viral RNA loads in oropharyngeal and cloacal swabs were determined at different time points during the observation period. Transmission of the H7N9 virus and the H7N7 strain by the birds was examined by investigating swab and organ samples from contact chickens. Moreover, the extent of viral replication in the upper respiratory tracts of ferrets was determined by measuring the viral RNA loads in nasal wash samples.
Chickens infected with A/Anhui/1/13 (H7N9) (C1, C2, C5, and C6) shed large viral RNA loads corresponding to substantial calculated TCID 50 -eqs from 2 to 10 dpi via the respiratory route ( Fig. 2A; Table 1 ), whereas chickens infected with A/turkey/Germany/AR534/13 (H7N7) (C7, C8, C11, and C12) shed virus at in cloacal swabs until 14 dpi (Fig. 2B) , indicating efficient and prolonged replication in the digestive tract. In contrast, the recent H7N7 virus was only detected until 7 dpi in cloacal swabs. Chickens with direct contact with H7N9-or H7N7-infected birds cloacally shed virus from day 5 p.e. to day 8 p.e., with slightly reduced amounts shed by chickens placed into direct contact with H7N7-infected birds. Serum antibodies reacting to the NP and H7 proteins were detected in all chicken samples by 14 dpi (Table 2) , with the exception of one chicken (C9) that was in direct contact with H7N7-infected chickens and developed antibodies against H7 but tested negative for the presence of antibodies against NP. Virus neutralization and HI assays revealed a subtype-specific cross-reactivity of the antibodies directed against the H7 protein by 14 dpi. In addition, we determined the viral replication and shedding patterns of the avian H7N9 virus and the recent H7N7 virus in infected pigeons. After infection with A/Anhui/1/13 (H7N9), the pigeons (P1 to P4) shed virus via the respiratory tract from 2 dpi (P2 and P3) to 4 dpi (P1 and P4) ( Fig. 2C; Table 3 ), although their RNA loads were far smaller than those of infected chickens. In oropharyngeal swabs, viral RNA was detectable until 7 dpi. Pigeons infected with A/turkey/Germany/AR534/13 (H7N7) (P5 to P8) shed similarly small RNA loads via respiratory secretions from 2 to 7 dpi. No cloacal shedding could be detected in pigeons infected with the avian H7N9 virus ( Fig. 2D; Table 3 ). In contrast, two of the H7N7-infected pigeons (P5 and P8) shed viral RNA in cloacal swabs at 4 dpi, indicating replication of the virus in the intestines. Antibodies against NP were detected by ELISA in the serum of every individually infected pigeon by 14 dpi, but all of the pigeons tested were negative by HI for the presence of antibodies against H7 (Table 4) . The results indicate that both viruses are capable of an initial infection and, to a certain extent, of replication in pigeons but that the induction of an H7-specific antibody-mediated immune reaction in that bird species is weak.
For the detection of viral RNA in nasal wash samples from ferrets, samples were collected every 2 days from all of the animals. All of the ferrets infected with A/Anhui/1/13 (H7N9) (F1 to F6) or A/turkey/Germany/AR534/13 (H7N7) (F7 to F12) shed large viral genome loads into nasal wash samples as early as 2 dpi and continued viral shedding until 8 dpi ( Fig. 2E; Table 5 ), but the H7N9 virus replicated to significantly larger amounts, as detected in nasal secretions than the H7N7 strain (P value ϭ 0.002165). No viral RNA was detected in the control animals (F13 and F14) except for in one animal on 4 dpi (euthanasia and dissection), with a very low viral-RNA load. All of the ferrets tested negative for influenza A virus NP-specific antibodies prior to infection (data not shown). Seroconversion of all of the infected ferrets was confirmed by the detection of antibodies against NP and H7 by 17 dpi (F1, F2, F7 , and F8) ( Table 6 ). The sera of H7N9-infected ferrets were able to neutralize the homologous H7N9 virus in the neutralization assay; however, neutralization of the H7N7 strain was weak. Antibodies induced after infection with the recent H7N7 virus displayed weak neutralizing activity against both the H7N9 and H7N7 viruses. Similar results were obtained with the HI assay.
Overall, the kinetics of H7N9 and H7N7 shedding were comparable in the avian and mammalian species investigated, with indications of enhanced replication of the H7N9 strain in ferrets.
Organ distribution of H7N9 and H7N7 viral RNA loads. In order to compare the distribution of the novel avian H7N9 virus and that of the recent H7N7 virus in the respiratory or digestive tract, one infected chicken and pigeon in each virus group was euthanized at 2 and 4 dpi, respectively, and their lungs and intestines were removed for viral RNA detection. Furthermore, a panel of organs was taken at 4 dpi from four additionally inoculated ferrets per virus group and one uninfected control animal. Immunohistochemical analysis was performed to detect viral antigen in the organs of infected animals. Viral RNA of the H7N9 virus or the H7N7 strain was not detected in the lungs of infected chickens at any time point (Fig. 3A ; Table 7 ). At 4 dpi, the replication of both A/Anhui/1/13 (H7N9) (C6) and A/turkey/Germany/AR534/13 (H7N7) (C12) could be detected in the intestines of infected chickens, with a larger load of the genome of the H7N9 virus. Interestingly, at 14 dpi, the H7N9 virus (C1 and C2) could still be detected in the intestine. No viral RNA was detected in the organs of contact chicken on day 12 p.e. Furthermore, no viral antigen could be detected by immunostaining of organ (lung, intestine) samples from infected chickens (data not shown).
The viral RNA loads in the lungs and intestines of pigeons after infection with the avian H7N9 virus or the recent H7N7 virus were determined at 2 and 4 dpi as well, but no A/Anhui/1/13 (H7N9) or A/turkey/Germany/AR534/13 (H7N7) viral RNA could be detected at these time points or at the end of the experiment (14 dpi) (Fig. 3B) . By immunohistochemical analysis, no viral antigen could be detected in organ (lung, intestine) samples from infected pigeons (data not shown).
In order to characterize the virus distribution in organs of ferrets infected with the avian H7N9 virus or the recent H7N7 strain, four animals per group and one uninfected control animal were euthanized at 4 dpi and their spleens, tracheas, left and right lungs, conchae, cerebella, and cerebra were taken. The RNAs of both the A/Anhui/1/13 (H7N9) (F3 to F6) and A/turkey/Germany/ AR534/13 (H7N7) (F9 to F12) viruses were detected in the upper respiratory tract (conchae, trachea) ( Fig. 3C; Table 8 ), whereas the RNA loads of both viruses were smaller in the lower respiratory tract and several samples, especially those from the H7N7-infected ferrets, were even negative. Interestingly, RNA of the H7N9 virus could be detected in the brains of all four ferrets and three of the four H7N7-infected animals. In all of the organs tested, the genome loads of the H7N9 virus were larger than those of the H7N7 strain, indicating better replication of A/Anhui/1/13 in that mammalian animal model. No virus was detected in the spleens of inoculated ferrets, excluding systemic infection/viremia. No viral RNA was detectable in any organ at 17 dpi, indicating that the ferrets were able to clear the viruses (data not shown). Immunohistological investigation of lung samples of infected ferrets at 4 dpi revealed an interstitial bronchopneumonia affecting single endothelial cells, pneumocytes, and bronchial epithelial cells in two of four H7N9-inoculated ferrets examined (F3 and F4) but in only one of four H7N7-infected animals (F11) (data not shown). Viral antigen could not be detected in the ferret brain samples examined by immunohistological techniques. In summary, the H7N9 and H7N7 viruses were comparably disseminated in the organs of infected chickens and pigeons; however, RNA of both viruses could be detected in the respiratory organs of ferrets, with the potential to disseminate into the brain and with lower C q values for the H7N9 virus.
DISCUSSION
In this study, we compared the infectivity and virulence of the novel avian H7N9 virus A/Anhui/1/13 with those of H7N7 LPAIV A/turkey/Germany/AR534/13, a representative of the H7N7 viruses recently circulating in poultry farms in Germany, in natural avian hosts (chickens, pigeons) and in a model mammalian host species (ferrets). Neither of the two strains induced any clinical signs in either inoculated or contact control chickens or in inoc- ulated pigeons. Comparable patterns of oropharyngeal and cloacal shedding were observed in chickens, and both viruses were transmitted to contact chickens, which shed slightly smaller amounts of the H7N7 isolate than of the H7N9 virus. Viral RNA was detected in the intestines of infected chickens at 4 dpi with larger RNA loads of the H7N9 virus than of the H7N7 strain, indicating a replication advantage in this avian host species. Neither the H7N9 virus nor the H7N7 strain was detected in the lungs of infected chickens. Obviously, lung tissue is not the primary location of viral replication, but rather tissues of the upper respiratory tract or the air sac epithelia. The lack of detection of viral antigen in lung tissues despite the presence of infectious virus in oropharyngeal swabs is in accordance to experimental data from Pantin-Jackwood and colleagues (29) . Therefore, oropharyngeal swab samples are more adequate than lung tissue for testing for the presence of the virus (or the viral genome). Antibodies directed against the H7 protein in chicken serum revealed only partial subtype-specific cross-reactivity, indicating that the overall antigenic difference between the HAs of the novel avian H7N9 virus and the H7N7 viruses currently circulating in Europe is low. Thus, reference antigens of contemporary European H7 viruses are suitable for the detection of H7N9/China-specific antibodies.
Respiratory shedding of both viruses by pigeons was detected, although only in very small amounts compared to those shed by infected chickens. Cloacal shedding by pigeons could be observed only for the H7N7 virus. Neither A/Anhui/1/13 (H7N9) nor A/turkey/Germany/AR534/13 (H7N7) could be detected in the organs of infected pigeons. Interestingly, both H7 viruses induced antibodies against NP in pigeons, but the infected pigeons failed to develop antibodies detectable by HI or ELISA against the H7 HA protein. Most probably, these data reflect the different sensitivities of the serological test systems used.
Zhang and colleagues have analyzed different strains of the novel avian H7N9 viruses isolated from different bird species from different habitats and from humans in different provinces of China for pathogenicity and transmission in chickens, mice, and ferrets (8) . Determining virulence in chickens, they obtained an intravenous pathogenicity index of 0, which is consistent with our result, although we chose the o.n. and therefore more natural application route. In contrast to our data, Ku and colleagues detected virus shedding by inoculated chickens for no longer than 2 days (30) . Likewise transmission between inoculated and naive chickens could not be demonstrated by the experimental setup of Ku and colleagues. Reasonable explanations for these differences from our data might be based on the different application routes (oculo-oro-nasal versus intranasal/intratracheal) and different methods of measurement of viral excretion. Further data from experimental infections of chickens, as well as genuine samples (swabs sampled from different poultry species), from the affected region rather support our findings of substantial replication in and shedding by chickens (29, 31, 32) .
The infected ferrets did not show any symptoms, and both of the viruses tested are therefore considered to be of low virulence in this mammalian model. Nevertheless, both the H7N9 virus and the H7N7 isolate replicated efficiently in the upper respiratory tract and were detected in nasal wash samples, with significantly larger loads of the H7N9 virus than of the H7N7 strain. Replication of both viruses in the lower respiratory tracts of ferrets was detectable, but the RNA loads were smaller than those in their noses and tracheas. Importantly, both viruses were able to spread into the brains of infected ferrets according to positive RT-qPCR results. It remains to be determined whether this occurred hematogenically as a result of systemic replication or by cranial nerve pathways, as has previously been shown for highly pathogenic H5N1 viruses in the ferret model (33) . Since no infection was detected in the spleen, systemic infection and hence hematogenic spread appear unlikely. However, the absence of neurological symptoms and a lack of detection of influenza viral antigen by immunohistopathology indicate that there is no massive virus replication activity in brain tissues. But it is also important to take into consideration the sensitivity limitations of direct antigen detection by staining, e.g., due to missing amplification in comparison with the real-time PCR. This is also reflected by our experience with HPAIV H5N1, where cycle threshold (C T ) values of Ͻ20 are regularly connected with positive antigen staining, while higher C T values, as observed here, often do not allow direct antigen detection. Interestingly, the results of a mouse infection study indicate that the human H7N9 isolates replicated more efficiently and were more lethal than the H7N9 viruses of direct avian origin (8) . They also tested two H7N9 viruses isolated from birds and three H7N9 strains isolated from humans in the ferret model and showed that all of the viruses replicated to similar levels in the nasal turbinates but that the viral loads in the tonsils, tracheas, and lungs were larger in ferrets infected with the human isolates, which were also able to replicate in the brain. Importantly, that group also reported respiratory droplet transmission between ferrets infected with H7N9 viruses isolated from humans, indicating the potential for human-to-human transmission of these viruses (8) . In contrast, Belser and coworkers found no evidence of efficient droplet-mediated transmission between ferrets (34) , and therefore, experimental conditions or strain variations might also influence transmission. In another study, Zhu and coworkers used the ferret model to evaluate the infectivity and transmissibility of another avian H7N9 virus isolated from a human, A/Shanghai/2/13, and found that the virus replicated in the upper and 
